Literature DB >> 2611881

The pressor hyperresponsiveness to phenylephrine unmasks sympathetic hypofunction in migraine.

M Boccuni1, M Alessandri, B M Fusco, F Cangi.   

Abstract

The pressor responsiveness to phenylephrine, an almost pure agonist of peripheral alpha-1-adrenoceptors, was studied in 32 migraine patients in headache-free intervals. Eighteen healthy volunteers served as a control group. Fourteen patients and 14 controls also underwent the tilt test. The following observations were made: (1) the pressor response to phenylephrine was significantly greater and longer lasting in patients than in controls; (2) the reflex decrease of heart rate did not differ in the two groups; (3) a normal orthostatic increase of blood pressure and heart rate occurred in migraineurs with hyperresponsiveness to phenylephrine. These findings suggest a supersensitivity of vascular adrenoceptors which is compatible with a chronic adrenergic deficiency in migraineurs. Since patients did not show an orthostatic hypotension in attack-free periods, the compensatory character of receptoral supersensitivity and the possible mechanisms of cardiovascular dysautonomia, which may occur during migraineous attack, were discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611881     DOI: 10.1046/j.1468-2982.1989.0904239.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

1.  How does fasting trigger migraine? A hypothesis.

Authors:  Turgay Dalkara; Kivilcim Kiliç
Journal:  Curr Pain Headache Rep       Date:  2013-10

2.  Migraine attack restores the response of vascular smooth muscle cells to nitric oxide but not to norepinephrine.

Authors:  Raffaele Napoli; Vincenzo Guardasole; Emanuela Zarra; Antonietta De Sena; Francesco Saccà; Antonio Ruvolo; Simona Grassi; Speranza Giugliano; Giovanna De Michele; Antonio Cittadini; Pietro Biagio Carrieri; Luigi Saccà
Journal:  World J Cardiol       Date:  2013-10-26

Review 3.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

4.  Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.

Authors:  Axel Lipp; Paola Sandroni; Phillip A Low
Journal:  J Neurol Sci       Date:  2009-04-05       Impact factor: 3.181

Review 5.  The autonomic nervous system and the regulation of arterial tone in migraine.

Authors:  L L Thomsen; J Olesen
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

Review 6.  Migraine and Autonomic Dysfunction: Which Is the Horse and Which Is the Jockey?

Authors:  Mitchell G Miglis
Journal:  Curr Pain Headache Rep       Date:  2018-02-23

7.  Autonomous control of cardiovascular reactivity in patients with episodic and chronic forms of migraine.

Authors:  Oleg V Mamontov; Laura Babayan; Alexander V Amelin; Rashid Giniatullin; Alexei A Kamshilin
Journal:  J Headache Pain       Date:  2016-05-11       Impact factor: 7.277

8.  Cardiovascular responses to cognitive stress in patients with migraine and tension-type headache.

Authors:  Rune B Leistad; Trond Sand; Kristian B Nilsen; Rolf H Westgaard; Lars Jacob Stovner
Journal:  BMC Neurol       Date:  2007-08-07       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.